Stemirac

Asset

Autologous bone marrow-derived mesenchymal stem cells promote tissue repair following spinal cord injury.

Stage
Stage not known
Modality
Cell therapy
Target
Not known
0
Indications
0
Trials
1
Developer

Indications

0

    In the full profile

    • Owner and partners1
    • Signals1

    Every asset’s record: target, stage, trials and the evidence behind it.

    See Pro

    Assets